154 related articles for article (PubMed ID: 36048906)
21. Functional characterization of botulinum neurotoxin serotype H as a hybrid of known serotypes F and A (BoNT F/A).
Kalb SR; Baudys J; Raphael BH; Dykes JK; Lúquez C; Maslanka SE; Barr JR
Anal Chem; 2015 Apr; 87(7):3911-7. PubMed ID: 25731972
[TBL] [Abstract][Full Text] [Related]
22. Development of human-like scFv-Fc antibodies neutralizing Botulinum toxin serotype B.
Rasetti-Escargueil C; Avril A; Chahboun S; Tierney R; Bak N; Miethe S; Mazuet C; Popoff MR; Thullier P; Hust M; Pelat T; Sesardic D
MAbs; 2015; 7(6):1161-77. PubMed ID: 26381852
[TBL] [Abstract][Full Text] [Related]
23. Synergistic capture of Clostridium botulinum type A neurotoxin by scFv antibodies to novel epitopes.
Gray SA; Barr JR; Kalb SR; Marks JD; Baird CL; Cangelosi GA; Miller KD; Feldhaus MJ
Biotechnol Bioeng; 2011 Oct; 108(10):2456-67. PubMed ID: 21538339
[TBL] [Abstract][Full Text] [Related]
24. RBC Adherence of Immune Complexes Containing Botulinum Toxin Improves Neutralization and Macrophage Uptake.
Al-Saleem FH; Sharma R; Puligedda RD; Elias M; Kattala CD; Simon PM; Simpson LL; Dessain SK
Toxins (Basel); 2017 May; 9(5):. PubMed ID: 28534855
[TBL] [Abstract][Full Text] [Related]
25. A Monoclonal Antibody Combination against both Serotypes A and B Botulinum Toxin Prevents Inhalational Botulism in a Guinea Pig Model.
Snow DM; Cobb RR; Martinez J; Finger-Baker I; Collins L; Terpening S; Syar ES; Niemuth N; Kobs D; Barnewall R; Farr-Jones S; Marks JD; Tomic MT
Toxins (Basel); 2021 Jan; 13(1):. PubMed ID: 33466411
[TBL] [Abstract][Full Text] [Related]
26. Extraction and inhibition of enzymatic activity of botulinum neurotoxins /B1, /B2, /B3, /B4, and /B5 by a panel of monoclonal anti-BoNT/B antibodies.
Kalb SR; Santana WI; Geren IN; Garcia-Rodriguez C; Lou J; Smith TJ; Marks JD; Smith LA; Pirkle JL; Barr JR
BMC Biochem; 2011 Nov; 12():58. PubMed ID: 22085466
[TBL] [Abstract][Full Text] [Related]
27. Sequence diversity of genes encoding botulinum neurotoxin type F.
Raphael BH; Choudoir MJ; Lúquez C; Fernández R; Maslanka SE
Appl Environ Microbiol; 2010 Jul; 76(14):4805-12. PubMed ID: 20511432
[TBL] [Abstract][Full Text] [Related]
28. Fully Human Monoclonal Antibodies Effectively Neutralizing Botulinum Neurotoxin Serotype B.
Matsumura T; Amatsu S; Misaki R; Yutani M; Du A; Kohda T; Fujiyama K; Ikuta K; Fujinaga Y
Toxins (Basel); 2020 May; 12(5):. PubMed ID: 32392791
[TBL] [Abstract][Full Text] [Related]
29. Affinity maturation of human botulinum neurotoxin antibodies by light chain shuffling via yeast mating.
Lou J; Geren I; Garcia-Rodriguez C; Forsyth CM; Wen W; Knopp K; Brown J; Smith T; Smith LA; Marks JD
Protein Eng Des Sel; 2010 Apr; 23(4):311-9. PubMed ID: 20156888
[TBL] [Abstract][Full Text] [Related]
30. In-Vivo Neutralization of Botulinum Neurotoxin Serotype E Using Rabbit Polyclonal Antibody Developed against BoNT/E Light Chain.
Rani S; Ponmariappan S; Sharma A; Kamboj DV; Jain AK
Protein Pept Lett; 2017; 24(6):495-502. PubMed ID: 28260503
[TBL] [Abstract][Full Text] [Related]
31. Clostridium botulinum strains producing BoNT/F4 or BoNT/F5.
Raphael BH; Bradshaw M; Kalb SR; Joseph LA; Lúquez C; Barr JR; Johnson EA; Maslanka SE
Appl Environ Microbiol; 2014 May; 80(10):3250-7. PubMed ID: 24632257
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of anti-botulinum neurotoxin single domain antibodies with additional optimization for improved production and stability.
Shriver-Lake LC; Zabetakis D; Goldman ER; Anderson GP
Toxicon; 2017 Sep; 135():51-58. PubMed ID: 28587791
[TBL] [Abstract][Full Text] [Related]
33. Monoclonal antibody-based lateral flow assay for detection of botulinum neurotoxin type A.
Chiao DJ; Wey JJ; Shyu RH; Tang SS
Hybridoma (Larchmt); 2008 Feb; 27(1):31-5. PubMed ID: 18294074
[TBL] [Abstract][Full Text] [Related]
34. Production of a neutralizing mouse-human chimeric antibody against botulinum neurotoxin serotype E.
Mukamoto M; Maeda H; Kohda T; Nozaki C; Takahashi M; Kozaki S
Jpn J Infect Dis; 2013; 66(1):46-50. PubMed ID: 23429085
[TBL] [Abstract][Full Text] [Related]
35. Molecular characterization of murine humoral immune response to botulinum neurotoxin type A binding domain as assessed by using phage antibody libraries.
Amersdorfer P; Wong C; Chen S; Smith T; Deshpande S; Sheridan R; Finnern R; Marks JD
Infect Immun; 1997 Sep; 65(9):3743-52. PubMed ID: 9284147
[TBL] [Abstract][Full Text] [Related]
36. Neutralization of Botulinum Neurotoxin Type E by a Humanized Antibody.
Derman Y; Selby K; Miethe S; Frenzel A; Liu Y; Rasetti-Escargueil C; Avril A; Pelat T; Urbain R; Fontayne A; Thullier P; Sesardic D; Lindström M; Hust M; Korkeala H
Toxins (Basel); 2016 Sep; 8(9):. PubMed ID: 27626446
[TBL] [Abstract][Full Text] [Related]
37. Antagonism of the intracellular action of botulinum neurotoxin type A with monoclonal antibodies that map to light-chain epitopes.
Cenci Di Bello I; Poulain B; Shone CC; Tauc L; Dolly JO
Eur J Biochem; 1994 Jan; 219(1-2):161-9. PubMed ID: 7508383
[TBL] [Abstract][Full Text] [Related]
38. Characterization of the monoclonal antibody response to botulinum neurotoxin type A in the complexed and uncomplexed forms.
Zhao H; Nakamura K; Kohda T; Mukamoto M; Kozaki S
Jpn J Infect Dis; 2012; 65(2):138-45. PubMed ID: 22446121
[TBL] [Abstract][Full Text] [Related]
39. Potent neutralization of botulinum neurotoxin/B by synergistic action of antibodies recognizing protein and ganglioside receptor binding domain.
Chen C; Wang S; Wang H; Mao X; Zhang T; Ji G; Shi X; Xia T; Lu W; Zhang D; Dai J; Guo Y
PLoS One; 2012; 7(8):e43845. PubMed ID: 22952786
[TBL] [Abstract][Full Text] [Related]
40. Engineered domain-based assays to identify individual antibodies in oligoclonal combinations targeting the same protein.
Meng Q; Garcia-Rodriguez C; Manzanarez G; Silberg MA; Conrad F; Bettencourt J; Pan X; Breece T; To R; Li M; Lee D; Thorner L; Tomic MT; Marks JD
Anal Biochem; 2012 Nov; 430(2):141-50. PubMed ID: 22922799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
